A detailed history of Virtus ETF Advisers LLC transactions in Alector, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 18,697 shares of ALEC stock, worth $31,971. This represents 0.04% of its overall portfolio holdings.

Number of Shares
18,697
Previous 18,362 1.82%
Holding current value
$31,971
Previous $83,000 4.82%
% of portfolio
0.04%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.34 - $6.58 $1,453 - $2,204
335 Added 1.82%
18,697 $87,000
Q2 2024

Aug 14, 2024

BUY
$4.19 - $6.23 $31,563 - $46,930
7,533 Added 69.56%
18,362 $83,000
Q1 2024

May 15, 2024

SELL
$5.69 - $8.08 $4,233 - $6,011
-744 Reduced 6.43%
10,829 $65,000
Q4 2023

Feb 15, 2024

SELL
$3.77 - $8.39 $4,742 - $10,554
-1,258 Reduced 9.8%
11,573 $92,000
Q3 2023

Nov 07, 2023

SELL
$5.2 - $8.77 $6,619 - $11,164
-1,273 Reduced 9.03%
12,831 $83,000
Q2 2023

Aug 14, 2023

BUY
$5.86 - $7.93 $19,466 - $26,343
3,322 Added 30.81%
14,104 $84,000
Q1 2023

May 15, 2023

SELL
$5.85 - $9.84 $24,283 - $40,845
-4,151 Reduced 27.8%
10,782 $66,000
Q4 2022

Feb 14, 2023

BUY
$6.88 - $9.55 $13,333 - $18,507
1,938 Added 14.91%
14,933 $137,000
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $794 - $1,280
97 Added 0.75%
12,995 $123,000
Q2 2022

Aug 12, 2022

BUY
$7.65 - $14.24 $42,396 - $78,918
5,542 Added 75.34%
12,898 $131,000
Q1 2022

May 16, 2022

SELL
$13.02 - $20.78 $5,767 - $9,205
-443 Reduced 5.68%
7,356 $105,000
Q4 2021

Feb 14, 2022

SELL
$19.35 - $25.54 $43,344 - $57,209
-2,240 Reduced 22.31%
7,799 $161,000
Q3 2021

Nov 15, 2021

SELL
$21.65 - $39.49 $11,193 - $20,416
-517 Reduced 4.9%
10,039 $229,000
Q2 2021

Aug 10, 2021

SELL
$15.5 - $22.48 $145,095 - $210,435
-9,361 Reduced 47.0%
10,556 $220,000
Q1 2021

May 17, 2021

BUY
$14.84 - $22.23 $5,253 - $7,869
354 Added 1.81%
19,917 $401,000
Q4 2020

Feb 12, 2021

BUY
$9.4 - $16.7 $84,900 - $150,834
9,032 Added 85.77%
19,563 $296,000
Q3 2020

Nov 13, 2020

SELL
$10.54 - $24.96 $15,061 - $35,667
-1,429 Reduced 11.95%
10,531 $111,000
Q2 2020

Aug 05, 2020

SELL
$21.87 - $33.11 $127,589 - $193,163
-5,834 Reduced 32.79%
11,960 $292,000
Q1 2020

May 14, 2020

SELL
$16.25 - $35.28 $42,087 - $91,375
-2,590 Reduced 12.71%
17,794 $429,000
Q4 2019

Feb 13, 2020

BUY
$14.17 - $20.3 $111,347 - $159,517
7,858 Added 62.73%
20,384 $351,000
Q3 2019

Nov 12, 2019

SELL
$14.42 - $22.2 $10,065 - $15,495
-698 Reduced 5.28%
12,526 $181,000
Q2 2019

Aug 13, 2019

BUY
$16.26 - $26.42 $215,022 - $349,378
13,224 New
13,224 $251,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $141M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.